The Role of Laparoscopic Surgery in Localized Pancreatic Neuroendocrine Tumours
- PMID: 33641016
- DOI: 10.1007/s11864-021-00824-5
The Role of Laparoscopic Surgery in Localized Pancreatic Neuroendocrine Tumours
Erratum in
-
Correction to: The Role of Laparoscopic Surgery in Localized Pancreatic Neuroendocrine Tumours.Curr Treat Options Oncol. 2021 Mar 18;22(4):36. doi: 10.1007/s11864-021-00842-3. Curr Treat Options Oncol. 2021. PMID: 33738586 No abstract available.
Abstract
Pancreatic neuroendocrine tumours (PNETs) are a rare and heterogeneous group of tumours with various clinical manifestations and biological behaviours. They represent approximately 2-4% of all pancreatic tumours, with an incidence of 2-3 cases per million people. PNETs are classified clinically as non-functional or functional, and pancreatic resection is recommended for lesions greater than 2 cm. The surgical approach can involve "typical" and "atypical" resections depending on the number, size and location of the tumour. Typical resections include pancreaticoduodenectomy, distal pancreatectomy enucleation and, rarely, total pancreatectomy. Atypical resections comprise central pancreatectomies or enucleations. Minimally invasive pancreatic resection has been proven to be technically feasible and safe in high-volume and specialized centres with highly skilled laparoscopic surgeons, with consolidated benefits for patients in the postoperative course. However, open and minimally invasive pancreatic surgery remains to have a high rate of complications; there is no specific technical contraindication to minimally invasive pancreatic surgery, but an appropriate patient selection is crucial to obtain satisfactory clinical and oncological outcomes.
Keywords: Laparoscopy; Minimally invasive surgery; Pancreatic surgery; Pnets.
References
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
-
- Thomaschewski M, Neeff H, Keck T, et al. Is there any role for minimally invasive surgery in NET? Rev Endocr Metab Disord. 2017 Dec;18(4):443–57. https://doi.org/10.1007/s11154-017-9436-x . - DOI - PubMed
-
- Brooks JC, Shavelle RM, Vavra-musser KN. Life expectancy in pancreatic neuroendocrine cancer. Clin Res Hepatol Gastroenterol. 2018;43:88–97. https://doi.org/10.1016/j.clinre.2018.08.005 . - DOI - PubMed
-
- Paniccia A, Edil BH, Schulick RD. Pancreatic Neuroendocrine Tumors : an Update. 2017;77:395–402. https://doi.org/10.1007/s12262-015-1360-2 .
-
- Mansour JC, Chavin K, Morris-stiff G, et al. Management of asymptomatic, well differentiated PNETs : results of the Delphi consensus process of the Americas Hepato- Pancreato Biliary Association. Int Hepato-Pancreato-Biliary Assoc. HPB (Oxford). 2019 May;21(5):515–23. https://doi.org/10.1016/j.hpb.2018.09.020 . - DOI
-
- Memeo R, Roselli S, Lupo L, Cherkaoui Z, Pessaux P. Laparoscopic management of neuroendocrine tumors : state-of- the-art. 2017. https://doi.org/10.21037/tgh.2017.11.19 .
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical